- Report
- April 2025
- 200 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- August 2024
- 150 Pages
Global
From €2908EUR$3,250USD£2,517GBP
€4340EUR$4,850USD£3,756GBP
- Report
- July 2025
- 464 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- January 2025
- 178 Pages
Global
From €4469EUR$4,995USD£3,869GBP
- Report
- October 2024
- 194 Pages
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 198 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 188 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- July 2025
- 175 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- April 2025
- 200 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- March 2025
- 175 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- February 2025
- 200 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- January 2025
- 175 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- April 2025
- 150 Pages
Global
From €2908EUR$3,250USD£2,517GBP
€4340EUR$4,850USD£3,756GBP
- Report
- April 2025
- 150 Pages
Global
From €2908EUR$3,250USD£2,517GBP
€4340EUR$4,850USD£3,756GBP
- Report
- March 2025
- 150 Pages
Global
From €2908EUR$3,250USD£2,517GBP
€4340EUR$4,850USD£3,756GBP
- Report
- July 2025
- 383 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 274 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 377 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- August 2024
- 136 Pages
Global
From €2683EUR$2,999USD£2,323GBP
- Report
- June 2025
- 150 Pages
Global
From €2415EUR$2,699USD£2,090GBP

Expectorants are a type of cough and cold drug used to treat chest congestion. They work by thinning and loosening mucus in the airways, making it easier to cough up and expel. Expectorants are often used in combination with other medications, such as decongestants, to provide relief from symptoms of the common cold. They are available in both over-the-counter and prescription forms.
Expectorants are generally considered safe for use in adults and children over the age of two. However, they should be used with caution in people with certain medical conditions, such as asthma, chronic bronchitis, and heart disease.
Some of the companies in the expectorant market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Sanofi. Show Less Read more